Table 4 Comparison of successful and failed selective biliary cannulation after successful afferent limb intubation
Variables | Total (N = 53) | Success (N = 39, 73.6%) | Fail (N = 14, 26.4%) | P value |
|---|---|---|---|---|
Age, yrs | 77 (68–84) | 77 (70–83) | 74 (62–86) | 0.480 |
Male, yrs | 75 (66–82) | 75 (68–82) | 69 (61–80) | 0.287 |
Female, yrs | 82 (78–86) | 81 (77–84) | 86 (85–87) | 0.182 |
Sex | 0.480 | |||
Male | 41 (77.4) | 29 (74.4) | 12 (85.7) | |
Female | 12 (22.6) | 10 (25.6) | 2 (14.3) | |
BMI, kg/m2 | 21.3 (19.2–22.9) | 21.5 (19.2–22.9) | 21.2 (20.2–22.1) | |
Indication for ERCP | 0.599 | |||
Choledocholithiasis | 48 (90.6) | 36 (92.3) | 12 (85.7) | |
Malignant obstruction | 5 (9.4) | 3 (7.7) | 2 (14.3) | |
Type of endoscope | 0.499 | |||
Cap-assisted gastroscope | 30 (56.6) | 21 (53.8) | 9 (64.3) | |
Duodenoscope | 23 (43.4) | 18 (46.2) | 5 (35.7) | |
Laboratory tests before ERCP | ||||
WBC, /µL | 8800 (6400–12300) | 8500 (6350–12450) | 9000 (7175–10550) | 0.880 |
AST, U/L | 162 (66–274) | 155 (67–288) | 189 (65–264) | 0.910 |
ALT, U/L | 139 (72–238) | 136 (60–243) | 158 (102–229) | 0.577 |
Total bilirubin, mg/dL | 2.6 (1.7–5.1) | 2.6 (1.8-5.0) | 2.6 (1.6–5.9) | 0.701 |
ALP, U/L | 256 (149–397) | 206 (124–357) | 323 (261–467) | 0.033 |
GGT, U/L | 291 (176–482) | 291 (156–434) | 291 (197–667) | 0.364 |
Amylase, U/L | 58 (36–79) | 59 (33–77) | 53 (44–147) | 0.538 |
Lipase, U/L | 36 (20–79) | 28 (20–51) | 50 (25–128) | 0.184 |
Complications | ||||
Bleeding | 0 | 0 | 0 | N/A |
Perforation | 1 (1.9) | 0 | 1 (7.1) | 0.264 |
Pancreatitis | 2 (3.8) | 1 (2.6) | 1 (7.1) | 0.462 |
Cholangitis | 0 | 0 | 0 | N/A |